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Clinical Research Article
Background: In this prospective, randomized, double-blind, placebo-controlled trial, we investigated the effect of a 
single dose of esmolol on the bispectral index (BIS) to endotracheal intubation during desflurane anesthesia. 
Methods: After induction of anesthesia, 60 patients were mask-ventilated with desflurane (end-tidal 1 minimum 
alveolar concentration) for 5 min and then received either normal saline, esmolol 0.5 or 1 mg/kg, 1 min prior to 
intubation (control, esmolol-0.5 and esmolol-1 groups, n = 20/group). BIS, mean arterial pressure, and heart rate 
were measured prior to anesthesia induction and esmolol administration, immediately preceding intubation (time 
point 0), and every minute for 5 min after intubation (time point 1 to 5). At time point 0, 1 and 5, 5 ml of arterial blood 
was taken to measure plasma concentrations of norepinephrine and epinephrine. 
Results: BIS increased significantly at 1 min after intubation when compared with pre-intubation values in all 
groups. Both mean arterial pressure and heart rate increased significantly 1 min after intubation when compared 
with preintubation values for all groups. Plasma epinephrine concentrations did not increase significantly after 
tracheal intubation in any of the groups. Norepinephrine increased at 1 min after intubation when compared with 
the preintubation values in the esmolol groups (P < 0.05). 
Conclusions: A single bolus of esmolol was unable to blunt the increase in BIS to endotracheal intubation during 
desflurane anesthesia. (Korean J Anesthesiol 2013; 64: 420-425)
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Introduction
The central sympathetic adrenergic response, which occurs 
during endotracheal intubation via an activation of the peripheral 
nervous system activation, results in an increase in the bispectral 
index (BIS) [1]. Accordingly, many interventions are used in an 
attempt to blunt the increase in BIS to endotracheal intubation 
[2-4]. Esmolol produces a dose-dependent attenuation of this 
adrenergic response and thus effectively prevents arousal 
reactions to noxious stimuli [2-5]. In a previous study, a single 
dose of esmolol (0.5 mg/kg) blunted the increase in BIS to 
endotracheal intubation with sevoflurane anesthesia, but not with 
desflurane anesthesia [5]. Additionally, desflurane is believed 
to induce greater neurocirculatory excitation - producing 
larger increases in sympathetic nervous activity, central venous 
pressure, and plasma norepinephrine (NE) concentrations - 
when compared with other inhaled anesthetics [6,7]. To the 
best of our knowledge, the effect of a single dose of esmolol on 
the catecholamine response to endotracheal intubation during 
desflurane anesthesia has not been investigated. As such, we 
hypothesized that a single dose of esmolol 1 mg/kg, which is a 
larger dose than that of the previous study [5], might blunt the 
BIS to endotracheal intubation during desflurane anesthesia. 
Hence, in this prospective, randomized, double blind, placebo-
controlled trial, we evaluate the effect of esmolol on these 
endpoints.
Materials and Methods
After receiving an approval from the Institutional Review 
Board, 60 adult patients were enrolled in the present study. 
Written informed consent was obtained in all cases, and all 
subjects had an American Society of Anesthesiologists physical 
status classification of either I or II, and were between 18 and 
65 years of age. Patients with cardiovascular, respiratory, or 
neurological disease including individuals taking cardiovascular 
medications or predicted difficulty in endotracheal intubation 
were excluded from the study. Patients were then randomly 
divided into 3 groups of 20 by computer-generated sequence, 
receiving either normal saline (control group), esmolol 0.5 mg/
kg (esmolol-0.5 group), or esmolol 1 mg/kg (esmolol-1 group). 
No premedication was administered in any case. On arrival 
to the operating room, all patients were monitored by electro-
cardiography, noninvasive blood pressure, and pulse oximetry. 
For BIS monitoring, a standard BIS monitor strip (BIS SensorⓇ; 
Aspect Medical Systems, Newton, MA, USA) was placed on the 
forehead so that BIS (Model A-2000; Aspect Medical Systems, 
Newton, MA, USA) could be measured continuously. 
The anesthetic technique used here was standardized: 
first anesthesia was induced with thiopental 5 mg/kg, after 
which rocuronium 0.6 mg/kg was administered intravenously 
to achieve neuromuscular blockade. Patients were manually 
ventilated to maintain EtCO2 between 35-40 mmHg, and 
desflurane was administered via facemask with a concomitant 
oxygen flow of 5 L/min. The concentration of desflurane was 
then increased until the end-tidal concentration reached 1 
minimum alveolar concentration (MAC), and administered for 
6 min prior to endotracheal intubation. A 20-gauge radial artery 
catheter was inserted for the purpose of continuous arterial 
pressure monitoring and blood sampling. One minute prior 
to endotracheal intubation, either normal saline, esmolol 0.5 
mg/kg or esmolol 1 mg/kg was administered intravenously to 
patients in a double-blinded manner. All syringes containing the 
study drug (same volume) were prepared by an anesthesiologist 
not involved in the study. One minute after the administration 
of the normal saline or esmolol, endotracheal intubation was 
performed by an experienced anesthesiologist, also not involved 
in the study and was accomplished in less than 20 seconds. 
After endotracheal intubation, the lungs were ventilated with 
50% air in oxygen and a 1 MAC end-tidal concentration of 
desflurane. No additional drugs were administered to any 
subjects, and no surgical procedures were performed during 
the study period. BIS, mean arterial blood pressure (MAP) 
and heart rate (HR) were measured prior to induction of 
anesthesia (awake), before esmolol injection (time point -1), 
immediately before intubation (time point 0), and each minute 
for 5 min after endotracheal intubation (time points 1 to 5). If 
systolic blood pressure decreased below 90 mmHg, or if the 
heart rate decreased below 50 beats/min, ephedrine 4 mg was 
administered intravenously. 
Arterial blood samplings (5 ml) were also collected at time 
points 0, 1, and 5. Within 20 min after collection, these samples 
underwent plasma separation by centrifuge at 3,000 r.p.m. for 7 
min, then were frozen to -70oC. All plasma epinephrine (EPI) 
and NE concentrations were measured by high-pressure liquid 
chromatography, with detection limits for EPI and NE of 20 
pg/ml and 20 pg/ml, respectively. The coefficients of variation 
were 3.49-6.14% for EPI and 1.51-6.33% for NE within runs, 
and 4.42-6.96% and 3.92-7.46% between runs. Samples with 
values less than the limits of detection were considered as 
having concentrations just below the limit of detection.
Based on a previous study [5], the sample size required 
to detect a mean difference of 10 in BIS with a SD of 10 and a 
power of 80% at an alpha level of 0.05 was 17 patients. In order 
to compensate for a dropout rate of 10%, 20 patients for each 
group were enrolled. All data were expressed as mean ± SD. 
SPSS version 15.0 (SPSS Inc., Chicago, IL, USA) was used for all 
statistical analyses. Specifically, the chi-square test was used to 
compare sex ratios between the three groups, while comparisons 
of age, weight, height, BIS, MAP, HR, and catecholamine values 
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were assessed using a one-way analysis of variance (ANOVA) 
with Bonferroni test. Value comparisons for each measurement 
were also performed using repeated measures of ANOVA. All 
significant results were also analyzed via Tukey’s post hoc test 
to determine whether time points produced values significantly 
different from preintubation. A P value < 0.05 was considered 
as statistically significant. 
Results
Sixty patients were enrolled in this study and none were 
excluded or failed to complete (Fig. 1). In total, data from 60 
patients were analyzed, with no differences observed in any of 
the demographic variables (Table 1). Additionally, no patient 
developed systolic blood pressure < 90 mmHg or HR < 50 
beats/min during the study period. 
The changes in BIS, MAP, and HR during the study period 
are shown in Fig. 2. At baseline, BIS values were between 
95 and 99, and subsequently decreased during anesthesia 
induction. No intergroup differences were observed in BIS 
before esmolol administration. At 1 min after intubation, BIS 
increased significantly in all groups when compared with 
preintubation (34 ± 6 to 49 ± 12 vs. 36 ± 5 to 49 ± 9 vs. 36 ± 5 to 
41 ± 5; P < 0.0001 vs. P < 0.0001 vs. P = 0.0001, respectively). 
However, the BIS value at this time point of the esmolol-1 
group was significantly lower than those of the other groups (P 
= 0.01) (Fig. 2A). The MAP did not differ among groups prior 
to endotracheal intubation, while the HR also did not differ 
among groups before the esmolol administration. Both the 
MAP and HR increased significantly at 1 min after intubation 
in all groups when compared with the preintubation values. 
The MAP did not differ among three groups after intubation, 
whereas the HR during the time period 1 to 5 min after intu-
bation in both the esmolol-0.5 and esmolol-1 groups was lower 
significantly than in the control groups (P < 0.0001) (Fig. 2B 
and 2C). Plasma EPI and NE concentrations during the study 
period are shown in Fig. 3. EPI did not increase significantly 
after endotracheal intubation in any of the groups, whereas 
NE increased 1 min after intubation when compared with the 
preintubation measurements in the esmolol groups (P < 0.05). 
There were no intergroup differences between EPI and NE at 
each measurement point. 
Discussion
In this study, a single bolus of esmolol was unable to attenuate 
the BIS and NE increases due to tracheal intubation during 
desflurane anesthesia, although the BIS value in the esmolol-1 
Table 1. Demographic Data
Control Esmolol-0.5 Esmolol-1
Sex (M/F)
Age (yr)
Weight (kg)
Height (cm)
10/10
41.7 ± 10.8
64.2 ± 10.3
165.4 ± 8.5
10/10
40.8 ± 10.9
62.9 ± 10.6
165.5 ± 11
10/10
41.8 ± 11
61.8 ± 10.3
165.1 ± 7.2
Values are presented as mean ± SD and the number of patients.  No 
statistically significant differences were observed among the three 
groups. Control: group with receiving normal saline, Esmolol-0.5: 
group with receiving esmolol 0.5 mg/kg, Esmolol-1: group with 
receiving esmolol 1 mg/kg at 1 min prior to intubation.
Fig. 1. Flow diagram of the randomized, 
controlled trial.
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Fig. 2. Changes in BIS (A), MAP (B), and HR (C) before and after 
tracheal intubation in the three groups. Values are presented as 
mean ± SD. *P < 0.05 when compared to preintubation value. †P < 
0.05 when compared with the values at the same time point in the 
control group. ‡P < 0.05 esmolol-1 group when compared to the 
value in the esmolol-0.5 group at the same time point. -1: before 
esmolol (normal saline) administration, 0: preintubation, 1 to 5: 1 
to 5 min after intubation. BIS: bispectral index, MAP: mean arterial 
pressure, HR: heart rate.
Fig. 3. Changes in epinephrine (A), and norepinephrine (B) before and after tracheal intubation in all three groups. Values are presented as 
mean ± SD. *P < 0.05 versus preintubation value. 0: preintubation, 1, 5: 1 and 5 min after intubation. 
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group was lower than the other groups. The hemodynamic 
responses to laryngoscopic stimulation were similarly not 
blunted. 
Previous studies have reported that anesthetic induction 
with desflurane increases cardiovascular responses via sym-
pathetic activation [8,9] and these responses could be blunted 
by drugs that decrease or block sympathetic outflow or activity, 
most notably opioids, β-adrenergic antagonists, and α2-ad re-
nergic agonists [10].
The change in plasma catecholamine concentrations during 
desflurane anesthesia is more prominent than with other 
inhaled anesthetics due to reflex sympathetic activation from 
rapid increases in anesthetic concentration or laryngoscopic 
stimulation [7,9]. Esmolol could exert its effect on BIS by in flu-
encing sympathetic activation [2-5]. However, in the current 
study plasma NE concentrations 1 min after esmolol admini-
stration were not different among the three groups. Similarly, 
the BIS did not decrease to a greater degree in the esmolol 
groups prior to tracheal intubation. This observation is con-
sistent with Berkenstadt’s report [11], though in that study 
propofol with fentanyl was used during anesthesia induction 
and maintenance. As such, we contend that the lack of an effect 
of esmolol on BIS and serum catecholamine concentrations 
during desflurane anesthesia may relate to the esmolol regimen 
used. 
Moreover, the plasma NE concentration in the esmolol group 
increased significantly following endotracheal intubation. 
Such an increase after the administration of esmolol has been 
reported in two settings: in individuals undergoing rapid 
sequence induction [12] and in patients given a single bolus 
of esmolol prior to intubation during isoflurane anesthesia 
[13]. Alterations in NE clearance after β-blockade, or greater 
baroreflex-mediated inhibition of the vasomotor center activity 
following pressor response in the control group was assumed to 
be one of the reasons [13]. Such increases in plasma NE con cen-
tration after a single bolus of esmolol have not been associated 
with desflurane anesthesia, but rather relate to the esmolol 
regimen. Because activation of the peripheral nerves via tracheal 
intubation is associated with increases in both BIS and circulating 
NE [1], it is unlikely that the admini stration of a single bolus could 
attenuate these sequelae. Here, sympathetic activation after 
laryngoscopic stimulation mediated by elevations in NE persisted 
despite the blunting of potential hemodynamic responses 
by opioids or β-adrenergic antagonists during desflurane 
anesthesia [7]. As such, regimens consisting of a loading dose 
followed by continuous infusion or simply continuous infusion 
of these drugs has been suggested as more efficacious in cases 
where the sympathetic system is substantially activated [3-4,14]. 
In our study, a single bolus administration of esmolol was 
unable to attenuate the hemodynamic responses to endo-
tracheal intubation, with MAP and HR values 1 min after 
intubation having increased from preintubation values. Single 
bolus administrations of esmolol have proven insufficient in 
suppressing immediate hemodynamic response to laryngo-
scopic stimulation. One previous study demonstrated 11 
different regimens and doses of esmolol as effective in attenu-
ating HR and BP after tracheal intubation in a dose-dependent 
manner [14].
Notably, there are some key limitations in the study described 
here. First, plasma NE concentrations were not measured prior 
to the administration of esmolol during anesthesia induction. 
Nevertheless, as concentrations of NE did not differ at 1 min 
post-esmolol administration, esmolol is not believed to affect 
plasma catecholamine concentrations during desflurane 
anesthesia. Second, while BIS can be influenced by several 
factors, including changes in cardiac output that influence the 
pharmacokinetics of anesthetics [15], alveolar concentrations of 
poorly soluble drugs such as desflurane are the least sensitive to 
such changes.
In conclusion, our results demonstrate that a single bolus 
administration of esmolol is unable to attenuate BIS increases 
and catecholamine responses resulting from endotracheal 
intubation during desflurane anesthesia. 
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